This compound is a pharmaceutical intermediate used in the manufacturing process of baloxavir marboxil. It is a linear molecule containing an amine and three ether functional groups, indicating moderate polarity and the ability to participate in hydrogen bonding.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 1228258-40-9
7-(Benzyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione
Pharmaceutical intermediate for baloxavir marboxil
(R)-7-(Benzyloxy)-12-((S)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl)-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione
Pharmaceutical intermediate for baloxavir marboxil
3-(benzyloxy)-4-oxo-4h-pyran-2-carboxylic acid
Pharmaceutical intermediate for baloxavir marboxil
Glycyl-L-prolyl-L-glutaminylglycyl-L-prolyl-L-glutamine
Peptide raw material
1H-Benzimidazole-2-butanoic acid, 5-(bis(2-chloroethyl)amino)-1-methyl-, 2-((2-(3-carboxypropyl)-1-methyl-1H-benzimidazol-5-yl)(2-chloroethyl)amino)ethyl ester
Bendamustine related compound
Boc-(s)-2-amino-2-(3-bromophenyl)acetic acid
Boc-protected amino acid intermediate
Benzyl 4-(hydroxymethyl)piperidine-1-carboxylate
pharmaceutical intermediate
2-(2,2-dimethoxyethoxy)ethanamine
CBEGMMFTEUNTQO-UHFFFAOYSA-N
COC(COCCN)OC